Exanthematous (maculopapular) drug eruption - UpToDate This topic will focus on the clinical presentation, diagnosis, and treatment of exanthematous drug eruptions Drug hypersensitivity in general, severe cutaneous drug reactions, cutaneous reactions to anticancer agents, and other types of cutaneous adverse drug reactions are discussed separately
Exanthematous (Morbilliform) Drug Eruption - DynaMed 2 , 3 typically seen as a widespread, pruritic, symmetrically distributed, maculopapular rash causes include a wide range of drugs, most commonly antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), antiseizure medications, and cancer therapeutics occurs in 1%-5% of first-time drug users
Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe . . . Morbilliform eruptions, which are a clinical reaction pattern characterized by erythematous macules and papules coalescing into patches that cover most of the skin surface, are one of the most common cutaneous findings in the inpatient setting
Maculopapular Rash | Diagnosis Disease Information Approximately 90% of patients who experience a drug hypersensitivity reaction present with a maculopapular rash 3 Drugs commonly implicated in hypersensitivity reactions include the following 1,3: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Deadly drug rashes: Early recognition and multidisciplinary care The most common inciting drugs are allopurinol, antibiotics (particularly sulfonamide antibiotics), antiepileptics, and NSAIDs 4 Immune checkpoint inhibitors, which are increasingly prescribed for malignancy, are associated with severe cutaneous drug eruptions, including SJS TEN 5
Drug Eruptions: Practice Essentials, Pathophysiology, Etiology Medications that are known for causing cutaneous reactions include antimicrobial agents, [6] nonsteroidal anti-inflammatory drugs (NSAIDs), cytokines, chemotherapeutic agents, anticonvulsants,